Microbiologics
Private Company
Funding information not available
Overview
Microbiologics is a well-established, privately held company that has operated for over 50 years as a critical supplier to the global diagnostics and life sciences industries. The company's business model is built on two pillars: 1) manufacturing and selling a diverse portfolio of standardized, test-ready microbial controls and reference materials, and 2) providing specialized CRO services for anti-infective testing, assay development, and viral stock production. With multiple R&D centers in the US and a recent strategic acquisition (SensID), Microbiologics is positioned to capitalize on the growing demand for quality assurance in diagnostic testing and drug development. It is a revenue-generating company with a strong market presence in quality control and a clear expansion strategy into molecular diagnostics and virology services.
Technology Platform
Portfolio of microbial stabilization, quantification, and delivery formats for quality control (lyophilized strains, quantified pellets, molecular standards) combined with CRO capabilities for anti-infective testing and virology.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Microbiologics competes with large, diversified life science suppliers (e.g., Thermo Fisher Scientific, Merck MilliporeSigma) that offer broad portfolios of QC materials, as well as smaller specialized manufacturers of microbial strains and controls. In the CRO space, it faces competition from large contract research organizations and specialized microbiology labs. Its differentiation lies in its deep expertise in microbiology, its extensive strain collection, and its focus on convenient, application-specific product formats.